Central Sensitisation in Nociceptive and Neuropathic Pain
ALGOS
The Experience of Nociceptive and Neuropathic Pain: Differences in Levels of Central Sensitization
1 other identifier
observational
185
1 country
1
Brief Summary
This study aims to investigate differences in central sensitization among patients with chronic nociceptive pain, neuropathic pain, and mixed pain conditions. Chronic pain is a complex and multidimensional phenomenon involving sensory, cognitive, emotional, and behavioral components, often sustained by mechanisms of central sensitization that contribute to pain persistence and treatment resistance. Using a multidimensional assessment approach, the study integrates self-report questionnaires, neuropsychological evaluation, psychological measures, treatment adherence assessment, and neurophysiological investigation through laser-evoked potentials (LEP). Participants will be evaluated at baseline and after 12 months to explore differences between pain types and longitudinal changes in central sensitization, cognitive functioning, emotional status, and engagement with treatment. The findings are expected to improve the understanding of neurobiological and psychosocial mechanisms underlying different chronic pain phenotypes and to support more personalized and effective pain management strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 20, 2027
April 20, 2026
April 1, 2026
2 years
December 22, 2025
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
neuropsychological assessment
Central Sensitization Inventory (CSI)
24 months
Neuropsychological assessment
Cognitive functions: Montreal Cognitive Assessment (MoCA)
24 months
Study Arms (3)
Nociceptive pain
Patients suffering from nociceptive pain
Mixed pain
Patients suffering from mixed pain
Neuropathic pain
Patients suffering from neuropathic pain
Interventions
Neuropsychological assessment Standardized and ad hoc test battery for comprehensive neuropsychological assessment
Eligibility Criteria
The sample size was estimated using G\*Power 3.1 based on the primary outcome measure, the Central Sensitization Inventory (CSI). A one-way ANOVA (omnibus test) comparing three groups (nociceptive pain, neuropathic pain, and mixed pain) with equal allocation (1:1:1) was assumed. The calculation was performed using a moderate effect size (f = 0.25), a two-sided significance level of α = 0.05, and a statistical power of 0.80. Based on these parameters, a minimum sample size of 159 participants was required (53 participants per group). Considering an expected dropout rate of approximately 15% over the 12-month follow-up period, the target enrollment was increased to approximately 185 participants, corresponding to about 62 participants per group.
You may qualify if:
- Age between 18 and 90 years
- Presence of chronic pain
- Diagnosis of nociceptive pain, neuropathic pain, mixed pain, or nociplastic pain
- Patients referring to the pain outpatient clinic
- Patients hospitalized in pain therapy units
- Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Presence of severe psychiatric disorders
- Presence of severe neurological disorders
- Presence of oncological diseases in terminal stage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Irccs Centro Neurolesi Bonino Pulejo
Messina, Sicily, 98066, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Psychologist
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 6, 2026
Study Start
December 15, 2025
Primary Completion (Estimated)
December 15, 2027
Study Completion (Estimated)
December 20, 2027
Last Updated
April 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share